NRX Pharmaceuticals, Inc. Increase (Decrease) in Income Taxes Payable
NRX Pharmaceuticals, Inc. (NRXP) reported Increase (Decrease) in Income Taxes Payable of $0 for the 9-month period ending 2020-09-30, per its 10-Q filed 2020-11-16.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable · last filed 2020-11-16
- NRX Pharmaceuticals, Inc. increase (decrease) in income taxes payable for the quarter ending 2020-09-30 was $0.00, a 100.00% decline year-over-year.
- NRX Pharmaceuticals, Inc. increase (decrease) in income taxes payable for the quarter ending 2020-06-30 was -$3.15K, a 107.73% decline year-over-year.
- NRX Pharmaceuticals, Inc. increase (decrease) in income taxes payable for the quarter ending 2020-03-31 was $3.15K, a 90.08% decline year-over-year.
- NRX Pharmaceuticals, Inc. increase (decrease) in income taxes payable for the quarter ending 2019-09-30 was $15.74K, a 55.03% decline year-over-year.
| Period end | Increase (Decrease) in Income Taxes Payable 3 month | Increase (Decrease) in Income Taxes Payable 6 month | Increase (Decrease) in Income Taxes Payable 9 month | Increase (Decrease) in Income Taxes Payable 12 month |
|---|---|---|---|---|
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | -$3.15K derived: sum of 2 quarters · filed 2020-11-16 | $0.00 10-Q · filed 2020-11-16 | |
| 2020-06-30 | -$3.15K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $0.00 10-Q · filed 2020-08-14 | ||
| 2020-03-31 | $3.15K 10-Q · filed 2020-05-15 | |||
| 2019-09-30 | $15.74K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | $56.41K derived: sum of 2 quarters · filed 2020-11-16 | $88.13K 10-Q · filed 2020-11-16 | |
| 2019-06-30 | $40.68K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $72.39K 10-Q · filed 2020-08-14 | ||
| 2019-03-31 | $31.72K 10-Q · filed 2020-05-15 | |||
| 2018-09-30 | $34.99K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $43.94K derived: sum of 2 quarters · filed 2019-11-14 | $48.05K 10-Q · filed 2019-11-14 | $0.00 10-Q · filed 2018-11-08 |
| 2018-06-30 | $8.95K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $13.06K 10-Q · filed 2019-08-14 | ||
| 2018-03-31 | $4.12K 10-Q · filed 2019-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |